Downstream Processing Featured Articles

1. Vaccine And Antibiotics Stabilized So Refrigeration Is Not Needed 7/10/2012

   Researchers funded by the National Institutes of Health have developed a new silk-based stabilizer that, in the laboratory, kept some vaccines and antibiotics stable up to temperatures of 140 degrees Fahrenheit. This provides a new avenue toward eliminating the need to keep some vaccines and antibiotics refrigerated, which could save billions of dollars every year and increase accessibility to third world populations.

2. New Cell Type Developed For Possible Treatment Of Alzheimer's And Other Brain Diseases 11/7/2012

   UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimer’s.

3. Acceleron Initiates Phase 2 Study Of ACE-536 To Treat Patients With Beta-Thalassemia 3/7/2013

   Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, recently announced the initiation of a phase 2 study of its novel, investigational protein therapeutic, ACE-536, to treat patients with beta-thalassemia, a genetic hematologic disorder causing chronic and life-threatening anemia and serious complications affecting the spleen, liver and heart.

4. MorphoSys And Heptares Sign Alliance To Develop Antibody Therapeutics Targeting GPCRs 2/13/2013

   MorphoSys AG (Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.

5. Therapure Announces Opening Of Custom Biologics Manufacturing Wing 4/20/2012

   Recently marked the official opening of Therapure Biopharma Inc.’s Custom Biologics Manufacturing Wing, which supports the development and manufacture of innovative medical treatments.

6. Laser Spotlight Reveals Machine 'Climbing' DNA 10/26/2012

   The experiments, reported in this week's Science, use laser light to generate very bright patches close to single cells. When coupled with fluorescent tags this 'spotlight' makes it possible to image the inner workings of cells fast enough to see how the molecular machines inside change size, shape, and composition in the presence of DNA.

7. GSK Receives FDA Approval For MenHibrix 6/14/2012

   GlaxoSmithKline plc announced recently that the U.S. Food and Drug Administration (FDA) has approved the vaccine MenHibrix [Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine]. 

8. Biotest Pharmaceuticals Announces Strategic Long-Term Manufacturing, Supply And License Agreement 1/10/2013

   Biotest Pharmaceuticals Corp. (BPC), a wholly owned U.S. subsidiary of Biotest AG (Dreieich, Germany), recently announced it has entered into a strategic long-term manufacturing, supply, and license agreement with ADMA Biologics,Inc.(ADMA).

9. International Stem Cell Corporation Demonstrates Positive Animal Efficacy Results In Metabolic Liver Disease Program 2/12/2013

   International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company") a California-based biotechnology company, today announced the conclusions from its study demonstrating the efficacy and safety of the hepatocyte-like cells (HLC) derived from human parthenogenetic stem cells (hpSC) in a well-established animal model of a congenital liver disorder associated with bilirubin metabolism.

10. Biosensors & Big Data: Implications For Biologics Developers 10/13/2020

    Dr. Caroline Loew’s company, Glympse Bio, develops injectable, tunable biosensors that she says will help biologics developers test and measure disease progression in vivo, enabling valuable, early visibility into therapeutic efficacy.